You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 5, 2026
Sale
Calculated transaction value
$67.03K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 2, 2026
Public filing date
Oct 5, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$541.7
Oct 2, 2026
First close after public filing
$541.62
Oct 6, 2026
30-day return after filing
+12.35%
Through Nov 4, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 120 shares @ $558.6
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000156
Filing cohort
Transactions in this filing
Showing 15 of 25
Trades
25
Issuers
1
Estimated value
$6.34M
Buys / sales
0 / 23
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Oct 2, 2026 | $661.94K |
| United Therapeutics Corp UTHR | Sale | Oct 2, 2026 | $221.49K |
| United Therapeutics Corp UTHR | Sale | Oct 2, 2026 | $561.59K |
| United Therapeutics Corp UTHR | Sale | Oct 2, 2026 | $697.47K |
| United Therapeutics Corp UTHR | Sale | Oct 2, 2026 | $168.94K |
| United Therapeutics Corp UTHR | Sale | Oct 2, 2026 | $416.04K |
| United Therapeutics Corp UTHR | Sale | Oct 2, 2026 | $238.03K |
| United Therapeutics Corp UTHR | Sale | Oct 2, 2026 | $400.07K |
| United Therapeutics Corp UTHR | Sale | Oct 2, 2026 | $88.46K |
| United Therapeutics Corp UTHR | Sale | Oct 2, 2026 | $133.78K |
| United Therapeutics Corp UTHR Current | Sale | Oct 2, 2026 | $67.03K |
| United Therapeutics Corp UTHR | Sale | Oct 2, 2026 | $67.28K |
| United Therapeutics Corp UTHR | Sale | Oct 2, 2026 | $45.11K |
| United Therapeutics Corp UTHR | Sale | Oct 2, 2026 | $45.33K |
| United Therapeutics Corp UTHR | Sale | Oct 2, 2026 | $68.48K |